ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1809

Clinical Characteristics of Older Age-Onset Behçet Syndrome Patients

Gul Guzelant1, Yilmaz Ozyazgan2, Cem Mat3, Vedat Hamuryudan1, Hasan Yazici1 and Emire Seyahi1, 1Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Istanbul University, Cerrahpasa Medical Faculty, Department of Ophthalmology, Istanbul, Turkey, 3Istanbul University, Cerrahpasa Medical Faculty, Department of Dermatology, Istanbul, Turkey

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, diagnosis and young adults

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The usual onset of Behçet syndrome (BS) is in the 3. decade. Older age-onset defined as fulfilling the International Study Group (ISG) criteria after 40 years (yrs) of age is rare and our knowledge about it is limited. One early study from our center had reported the severity of eye disease was not different between early onset (≤24 yrs) and late onset (≥25 yrs) group, while the total clinical activity scores were smaller in the late onset group (1). While there is ambiguity in the definition of older onset, a few case series (2-4) coming mostly from ophthalmology or dermatology settings describe a similar or less severe clinical picture among late onset patients (pts) compared to that seen in early onset. The aim of this retrospective study was to evaluate clinical characteristics of pts with older onset BS pts, to compare them with a group of classic onset BS pts.

Methods: The charts of 3335 BS pts who were registered between Jan 2000 and Dec 2010 were reviewed retrospectively. Pts who fulfilled the ISG criteria for BS after 40 yrs of age (≥ 40) were defined as older onset, while those who fulfilled the criteria before 30 yrs of age as classic onset. For each older onset chart, 2 consecutively registered early onset charts were selected. Only clinical manifestations at initial presentation were recorded. A clinical activity index (1) was modified, calculated for each pt.

Results: There were only 134(70 M/64 F) pts with older onset BS, which gave a prevalence of 4% in the whole cohort. Age of onset was 40-44 yrs of age in 54 pts, 45-49 yrs in 47 and 50+ in 32.  As controls 268(163 M/105 F) classic onset pts were selected. Demographic/Clinical characteristics among older and classic onset pts are described for males and females separately, in Table. The frequency of skin manifestations, arthritis and eye disease as well as the mean clinical activity scores were significantly higher among male classic onset pts compared to older onset male pts. Interestingly, frequency of those with positive pathergy test, vascular involvement and severe eye involvement did not seem to be different among older onset and classic onset male pts. Clinical characteristics and total activity scores were similar between the older onset and classic onset groups among females (Table). The main limitation is that the information was based solely on patient’s charts and outcome information was not available.  

Conclusion: Compared to classic onset pts, males tend to be less frequent in the older cohort. At presentation, older onset male pts had significantly less frequent skin, joint, eye disease, and significantly lower total activity scores compared with classic onset pts. There was no difference between the classic and older onset group, among females.    

References: 1-Yazici H et al.Ann Rheum Dis.1984.2-Tsai J et al.J Eur Acad Dermatol Venereol.2008.3-Hamzaoui A et al.Acta Medica Iranica 2014.4-Citirik M et al.Ophthalmologica.2011.

 

 


Disclosure: G. Guzelant, None; Y. Ozyazgan, None; C. Mat, None; V. Hamuryudan, None; H. Yazici, None; E. Seyahi, None.

To cite this abstract in AMA style:

Guzelant G, Ozyazgan Y, Mat C, Hamuryudan V, Yazici H, Seyahi E. Clinical Characteristics of Older Age-Onset Behçet Syndrome Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/clinical-characteristics-of-older-age-onset-behcet-syndrome-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-of-older-age-onset-behcet-syndrome-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology